XORTX Therapeutics Inc.
XRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729214
No open-market purchases or sales by XORTX Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $92.8K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding XORTX Therapeutics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 4 | +4 |
| Shares | 0 | 24.2K | +24.2K |
| Value | $0 | $49.0K | +$49.0K |
New holders (4)
Institutions that held XORTX Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CIBC World Markets Inc. | 22,500 | $46.0K | 0.00% |
| UBS Group AG | 1,112 | $2.00K | 0.00% |
| Royal Bank of Canada | 552 | $1.00K | 0.00% |
| Bank of America Corp | 2 | $0 | 0.00% |
Sold out (0)
Institutions that held XORTX Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
None.